SPDL1 and diffuse large B-cell lymphoma: In addition, patients with advanced stage, IPI grades > 2, non-GCB subtype, elevated LDH and β2-M levels had higher sPD-L1 level, which also suggests that sPD-L1 levels have a potential of predicting DLBCL progression.